Global Anti-inflammatory Drugs Market 2022-2028

May 2022 | 71 pages | ID: G8E1D8BB351AEN
Gen Consulting Company

Abstracts

Anti-inflammatory drugs block certain substances in the body that cause inflammation ((redness, swelling, and pain)). They are used to treat many different conditions. According to market research study published by Gen Consulting Company, the market size of the global anti-inflammatory drugs sector is expected to rise by USD 44 billion with a CAGR of 6.1% by the end of 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global anti-inflammatory drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the anti-inflammatory drugs industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug class, indication, route of administration, and region. The global market for anti-inflammatory drugs can be segmented by drug class: biologics & biosimilars, non-steroidal anti-inflammatory drugs (NSAIDs), steroids, others. Globally, the biologics & biosimilars segment made up the largest share of the anti-inflammatory drugs market. Anti-inflammatory drugs market is further segmented by indication: autoimmune diseases, respiratory diseases, others. The autoimmune diseases segment captured the largest share of the market in 2021. Based on route of administration, the anti-inflammatory drugs market is segmented into: parenteral, oral, topical, inhalational. On the basis of region, the anti-inflammatory drugs market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest revenue share in 2021.

By drug class:

• biologics & biosimilars
• non-steroidal anti-inflammatory drugs (NSAIDs)
• steroids
• others

By indication:

• autoimmune diseases
• respiratory diseases
• others

By route of administration:

• parenteral
• oral
• topical
• inhalational

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The global anti-inflammatory drugs market report offers detailed information on several market vendors, including AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Biogen Inc., Bristol-Myers Squibb Company, Cipla Limited, Dr. Reddys Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Glenmark Pharmaceuticals Limited, GSK plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global anti-inflammatory drugs market.
• To classify and forecast the global anti-inflammatory drugs market based on drug class, indication, route of administration, region.
• To identify drivers and challenges for the global anti-inflammatory drugs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global anti-inflammatory drugs market.
• To identify and analyze the profile of leading players operating in the global anti-inflammatory drugs market.

Why Choose This Report

• Gain a reliable outlook of the global anti-inflammatory drugs market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY DRUG CLASS

Biologics & biosimilars
Non-steroidal anti-inflammatory drugs (NSAIDs)
Steroids
Others

PART 6. MARKET BREAKDOWN BY INDICATION

Autoimmune diseases
Respiratory diseases
Others

PART 7. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Parenteral
Oral
Topical
Inhalational

PART 8. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 9. KEY COMPANIES

AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Biogen Inc.
Bristol-Myers Squibb Company
Cipla Limited
Dr. Reddys Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche AG
Glenmark Pharmaceuticals Limited
GSK plc
Johnson & Johnson
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER